Semaglutide
A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity
Novo Nordisk · Phase 3 · Completed · Enrollment 201
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Semaglutide | 72.5% | 61.8% | 53.4% | 37.4% |
| Placebo | 17.7% | 8.1% | 4.8% | 3.2% |
Not shown
Every selected arm is drawn.